These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 23588086)

  • 1. Co-inoculation of baculovirus and FMDV vaccine in mice, elicits very early protection against foot and mouth disease virus without interfering with long lasting immunity.
    Quattrocchi V; Molinari P; Langellotti C; Gnazzo V; Taboga O; Zamorano P
    Vaccine; 2013 May; 31(24):2713-8. PubMed ID: 23588086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjuvant effect of Cliptox on the protective immune response induced by an inactivated vaccine against foot and mouth disease virus in mice.
    Batista A; Quattrocchi V; Olivera V; Langellotti C; Pappalardo JS; Di Giacomo S; Mongini C; Portuondo D; Zamorano P
    Vaccine; 2010 Aug; 28(38):6361-6. PubMed ID: 20637310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early protection against foot-and-mouth disease virus in cattle using an inactivated vaccine formulated with Montanide ESSAI IMS D 12802 VG PR adjuvant.
    Quattrocchi V; Pappalardo JS; Langellotti C; Smitsaart E; Fondevila N; Zamorano P
    Vaccine; 2014 Apr; 32(19):2167-72. PubMed ID: 24631088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Novel Particulate Delivery System Based on Antigen-Zn
    Li S; Yang Y; Lin X; Li Z; Ma G; Su Z; Zhang S
    Mol Pharm; 2020 Aug; 17(8):2952-2963. PubMed ID: 32539415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of mucosal immune responses and protection of cattle against direct-contact challenge by intranasal delivery with foot-and-mouth disease virus antigen mediated by nanoparticles.
    Pan L; Zhang Z; Lv J; Zhou P; Hu W; Fang Y; Chen H; Liu X; Shao J; Zhao F; Ding Y; Lin T; Chang H; Zhang J; Zhang Y; Wang Y
    Int J Nanomedicine; 2014; 9():5603-18. PubMed ID: 25506214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel immunogenic baculovirus expressed virus-like particles of foot-and-mouth disease (FMD) virus protect guinea pigs against challenge.
    Bhat SA; Saravanan P; Hosamani M; Basagoudanavar SH; Sreenivasa BP; Tamilselvan RP; Venkataramanan R
    Res Vet Sci; 2013 Dec; 95(3):1217-23. PubMed ID: 23969204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coinjection of a vaccine and anti-viral agents can provide fast-acting protection from foot-and-mouth disease.
    You SH; Kim T; Choi JH; Park G; Lee KN; Kim B; Lee MH; Kim HS; Kim SM; Park JH
    Antiviral Res; 2017 Jul; 143():195-204. PubMed ID: 28454913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunity of foot-and-mouth disease serotype Asia 1 by sublingual vaccination.
    Chen HT; Liu YS
    PLoS One; 2013; 8(5):e63839. PubMed ID: 23717497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delivery of synthetic RNA can enhance the immunogenicity of vaccines against foot-and-mouth disease virus (FMDV) in mice.
    Borrego B; Rodríguez-Pulido M; Mateos F; de la Losa N; Sobrino F; Sáiz M
    Vaccine; 2013 Sep; 31(40):4375-81. PubMed ID: 23859841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of a high potency O1 Manisa monovalent vaccine against heterologous challenge with foot-and-mouth disease virus of O/SEA/Mya-98 lineage in sheep.
    Singanallur NB; Pacheco JM; Arzt J; Stenfeldt C; Fosgate GT; Rodriguez L; Vosloo W
    Antiviral Res; 2017 Sep; 145():114-122. PubMed ID: 28780422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of Protective Immunity against Inactivated Iranian Isolate of Foot-and-Mouth Disease Virus Type O/IRN/2007 Using Gamma Ray-Irradiated Vaccine on BALB/c Mice and Guinea Pigs.
    Motamedi-Sedeh F; Soleimanjahi H; Jalilian AR; Mahravani H; Shafaee K; Sotoodeh M; Taherkarami H; Jairani F
    Intervirology; 2015; 58(3):190-6. PubMed ID: 26202581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mincle and STING-Stimulating Adjuvants Elicit Robust Cellular Immunity and Drive Long-Lasting Memory Responses in a Foot-and-Mouth Disease Vaccine.
    Lee MJ; Jo H; Shin SH; Kim SM; Kim B; Shim HS; Park JH
    Front Immunol; 2019; 10():2509. PubMed ID: 31736952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant adenovirus expressing type Asia1 foot-and-mouth disease virus capsid proteins induces protective immunity against homologous virus challenge in mice.
    Zhou G; Wang H; Wang F; Yu L
    Res Vet Sci; 2013 Jun; 94(3):796-802. PubMed ID: 23267820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of synthetic peptide vaccines against foot-and-mouth disease type A].
    Tang H; Liu X; Fang Y; Jiang S; Pan L; Lv J; Zhang Z; Zhou P; Zhang Y; Wang Y
    Wei Sheng Wu Xue Bao; 2013 Jun; 53(6):596-607. PubMed ID: 24028062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term humoral immunity induced by CVC1302-adjuvanted serotype O foot-and-mouth disease inactivated vaccine correlates with promoted T follicular helper cells and thus germinal center responses in mice.
    Du L; Chen J; Hou L; Yu X; Zheng Q; Hou J
    Vaccine; 2017 Dec; 35(51):7088-7094. PubMed ID: 29129452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined administration of synthetic RNA and a conventional vaccine improves immune responses and protection against foot-and-mouth disease virus in swine.
    Borrego B; Blanco E; Rodríguez Pulido M; Mateos F; Lorenzo G; Cardillo S; Smitsaart E; Sobrino F; Sáiz M
    Antiviral Res; 2017 Jun; 142():30-36. PubMed ID: 28315707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of novel strategies to control foot-and-mouth disease: marker vaccines and antivirals.
    Grubman MJ
    Biologicals; 2005 Dec; 33(4):227-34. PubMed ID: 16289996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A proposal for an alternative quality control test procedure for inactivated vaccines against food-and-mouth disease virus.
    Molin-Capeti KC; Sepulveda L; Terra F; Torres-Pioli MF; Costa-Casagrande T; França SC; Thomaz-Soccol V
    Vaccine; 2013 Feb; 31(9):1349-52. PubMed ID: 23267841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA vaccines expressing B and T cell epitopes can protect mice from FMDV infection in the absence of specific humoral responses.
    Borrego B; Fernandez-Pacheco P; Ganges L; Domenech N; Fernandez-Borges N; Sobrino F; Rodríguez F
    Vaccine; 2006 May; 24(18):3889-99. PubMed ID: 16563575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of ENABL® adjuvant to increase the potency of an adenovirus-vectored foot-and-mouth disease virus serotype A subunit vaccine.
    Barrera J; Schutta C; Pisano M; Grubman MJ; Brake DA; Miller T; Kamicker BJ; Olutunmbi F; Ettyreddy D; Brough DE; Butman BT; Neilan JG
    Vaccine; 2018 Feb; 36(8):1078-1084. PubMed ID: 29358056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.